Keeping in Touch (KiT) With Youth as They Transition to Adult Type 1 Diabetes Care
KiT
1 other identifier
interventional
234
1 country
6
Brief Summary
The investigators are testing the effectiveness of an eHealth digital tool co-designed with patients and providers to improve diabetes self-efficacy in young adults as they transition to adult type 1 diabetes care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2022
CompletedFirst Submitted
Initial submission to the registry
May 29, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2025
CompletedApril 29, 2026
April 1, 2026
3.6 years
May 29, 2022
April 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To test the effect of a text message-based T1D transition intervention compared to control at 12 months in the Self-Efficacy for Diabetes management scale. A higher score indicates better self-efficacy.
The primary objective of this study is to compare the effectiveness of a text message-based T1D transition intervention that will personalize transition education and support, as an adjunct to usual T1D transition care versus usual transition care alone on a patient-reported outcome measure (PROM) called the Self-Efficacy for Diabetes Management (SEDM) scale, measured at 12 months after enrollment in the study. The SEDM has scale from 1-10 where 1 denotes 'not at all sure' and 10 denotes 'completely sure' where higher scores mean better outcomes. Minimal clinically important difference is 10%.
12 months
Secondary Outcomes (17)
Compare text message-based T1D transition intervention to control at 6 months in the Self-Efficacy for Diabetes management scale. Higher score indicates better self efficacy.
6 months
To compare diabetes self-efficacy in the intervention vs. control group at baseline. A higher score indicates better self efficacy.
Baseline
Evaluate the impact of this text message-based intervention compared to usual care at 12 months using the Readiness Assessment of Emerging Adults with Type 1 Diabetes Diagnosed in Youth (READDY) Tool. Higher scores indicating more confidence
12 months
Evaluate the impact of this text message-based intervention compared to usual care at 6 months using the Readiness Assessment of Emerging Adults with Type 1 Diabetes Diagnosed in Youth (READDY) Tool. Higher scores indicating more confidence
6 months
To compare transition readiness in the intervention and control groups at baseline using the Readiness Assessment of Emerging Adults with Type 1 Diabetes Diagnosed in Youth (READDY) Tool. Higher scores indicating more confidence
Baseline
- +12 more secondary outcomes
Other Outcomes (4)
Evaluation of participant engagement with the intervention with number of participants who are engaging with intervention messages
12 months
Evaluation of participant engagement with the intervention looking at which types of messages are the most and least engaged with
12 months
Evaluation of intervention fidelity
12 months
- +1 more other outcomes
Study Arms (2)
eHealth Tool
EXPERIMENTALThe Intervention is a text messaging algorithm that will operate like a chatbot, querying adolescents with T1D about their confidence with different aspects of T1D self-management as they are preparing to transition to adult diabetes care. The intervention has 4 components of messaging: personalized Educational Content, Standard Educational Curriculum, Provide participant compensation for filling out the questionnaires, Question \& Answer feature.
Control
NO INTERVENTIONParticipants randomized to the control arm will also be offered the same incentives to complete questionnaires (outcome measures) but will not receive any other components of the intervention - no personalized/customized support or diabetes resource messages and no reminders. Control arm participants will continue with their usual T1D transition care.
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosed with type 1 diabetes, ascertained from patient's medical chart
- Receiving out-patient care for T1D at a pediatric diabetes center participating in this study
- Is within 6 months of either planned transfer or 18th birthday so research coordinator can approach patient and inform them about the study, and then can be re-approached for consenting and enrollment only within 3-4 months of either: planned transfer to adult diabetes care OR 18th birthday
- Proficient in written and spoken English or French
- Possession of their own personal mobile device that can support SMS with sufficient capacity to send and receive SMS/texts
- Valid and working mobile phone number
- Valid email address
- Willing to engage with intervention if randomized to intervention arm
- Willing to complete study outcome measures (questionnaires) at all study time-points regardless of which arm they are randomized to: baseline, 6 months, and 12 months
- Willing to provide informed consent
You may not qualify if:
- Unable to carry out their diabetes care independently due to an intellectual or neurocognitive disability; discerned from medical chart during pre-screening
- Non-resident of Ontario or Quebec
- Planning to move out of either province in the next 6-12 months and after moving, will not be receiving diabetes care in either province and/or will not have a valid and working mobile number
- Currently enrolled in any other clinical research trial with an SMS-based intervention
- Currently enrolled in another diabetes intervention trial that will continue beyond the final pediatric diabetes visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Trillium Health Partnerscollaborator
- University Health Network, Torontocollaborator
Study Sites (6)
Oak Valley Health
Markham, Ontario, L9P1S4, Canada
Trillium Health Partners
Mississauga, Ontario, L5B2V2, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H8L1, Canada
The Hospital for Sick Children
Toronto, Ontario, M5G1X8, Canada
McGill University Health Center
Montreal, Quebec, H3G1A4, Canada
Saint Justine Hospital
Montreal, Quebec, H3T1C5, Canada
Related Publications (1)
Sanmugalingham G, Mok E, Cafazzo JA, Desveaux L, Brazeau AS, Booth GL, Greenberg M, Kichler J, Rac VE, Austin P, Goldbloom E, Henderson M, Landry A, Zenlea I, Taylor M, Nakhla M, Shulman R. Text message-based intervention, Keeping in Touch (KiT), to support youth as they transition to adult type 1 diabetes care: a protocol for a multisite randomised controlled superiority trial. BMJ Open. 2023 May 8;13(5):e071396. doi: 10.1136/bmjopen-2022-071396.
PMID: 37156577DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 29, 2022
First Posted
June 28, 2022
Study Start
January 16, 2022
Primary Completion
August 23, 2025
Study Completion
August 23, 2025
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share